Kiora Pharmaceuticals KPRX
NASDAQ KPRX
$1.42 +0.04 (+2.78%)
As of: Nov 11, 2026 · 12:27 PM EST

Kiora Pharmaceuticals (KPRX) Price to Sales (2016 - 2026)

Updated

Kiora Pharmaceuticals' (KPRX) Price to Sales was 634.66 for Q1 2025, compared with 1.16 a year earlier.

Analysis

Kiora Pharmaceuticals (KPRX) Price to Sales (2016 - 2026) Analysis & Trends

For FY2024, Price to Sales at Kiora Pharmaceuticals was 0.80.

  • By year, Price to Sales came in at 74831.25 in FY2020.
  • The Q1 2025 figure ranks as the highest quarterly Price to Sales since Q4 2020.
  • Per Business Quant data, the three quarters before Q1 2025 came in at 0.80 (Q4 2024), 0.96 (Q3 2024) and 1.09 (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Kiora Pharmaceuticals 8.53 Mn -58.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 56.89
Mar 31, 2026 55.31
Mar 31, 2025 634.66
Dec 31, 2024 0.80
Sep 30, 2024 0.96
Jun 30, 2024 1.09
Mar 31, 2024 1.16
Sep 30, 2023 555.37
Jun 30, 2023 232.62
Mar 31, 2023 688.17
Sep 30, 2022 545.07
Jun 30, 2022 17,875.97
Mar 31, 2022 25,135.72
Sep 30, 2021 75,000.03
Dec 31, 2020 74,831.25
Dec 31, 2019 474.66
Sep 30, 2019 144.25
Jun 30, 2019 146.14
Mar 31, 2019 171.49
Dec 31, 2018 399.40
API Access

Kiora Pharmaceuticals Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=KPRX&period=max&api_key=YOUR_API_KEY